心源性休克患者的腺苷血浆水平与A2A受体表达
这项单中心前瞻性观察研究纳入心源性休克(n=16)、急性心力衰竭(n=16)和急性心肌梗死(n=16)患者,在入院时和24小时后检测动脉血浆腺苷水平及外周血单核细胞A2A受体表达,并评估包括全身血管阻力在内的血流动力学参数。心源性休克患者入院时平均腺苷血浆水平为2.74 ± 1.03 µM,显著高于急性心力衰竭(1.33 ± 0.27)和急性心肌梗死(1.19 ± 0.27)(正常范围0.4-0.8 µM)(p < 0.0001)。腺苷血浆水平与全身血管阻力之间无显著相关性。心源性休克患者入院24小时后平均腺苷血浆水平从2.74 ± 1.03显著降至1.53 ± 0.68(p < 0.001)。心源性休克患者平均A2A受体表达为1.18 ± 0.11,显著低于急性心力衰竭的1.39 ± 0.08(p = 0.005)。作者认为这可能参与心源性休克的病理生理过程。
要点
- 心源性休克患者入院时平均腺苷血浆水平2.74 ± 1.03 µM,显著高于急性心力衰竭(1.33 ± 0.27)和急性心肌梗死(1.19 ± 0.27)(正常范围0.4-0.8 µM)(p < 0.0001)。
- 心源性休克患者入院24小时后平均腺苷血浆水平从2.74 ± 1.03显著降至1.53 ± 0.68(p < 0.001)。
- 心源性休克患者平均A2A受体表达1.18 ± 0.11,显著低于急性心力衰竭的1.39 ± 0.08(p = 0.005)。
- 腺苷血浆水平与全身血管阻力之间无显著相关性。
- 作者认为高腺苷血浆水平和低A2A受体表达可能参与心源性休克的病理生理过程。
适用人群与场景
- 心源性休克患者(n=16)、急性心力衰竭患者(n=16)和急性心肌梗死患者(n=16),来自法国马赛Hopital Nord单中心。
研究设计与关键结果
- 研究类型为前瞻性观察研究,单中心(Hopital Nord,马赛,法国),纳入心源性休克(n=16)、急性心力衰竭(n=16)和急性心肌梗死(n=16)患者,无干预。
- 入院时平均腺苷血浆水平:心源性休克2.74 ± 1.03 µM vs 急性心力衰竭1.33 ± 0.27 µM vs 急性心肌梗死1.19 ± 0.27 µM(正常范围0.4-0.8 µM)(p < 0.0001)。
- 心源性休克患者平均腺苷血浆水平24小时内从2.74 ± 1.03 µM降至1.53 ± 0.68 µM(p < 0.001)。
- 平均A2A受体表达:心源性休克1.18 ± 0.11 vs 急性心力衰竭1.39 ± 0.08(p = 0.005)。
- 腺苷血浆水平与全身血管阻力之间无显著相关性。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为心源性休克患者入院时高腺苷血浆水平和低A2A受体表达可能参与心源性休克的病理生理过程。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate whether adenosine A2A receptors lead to vasodilation and positive inotropic function under stimulation and whether they play a role in the control of blood pressure in patients with cardiogenic shock.
DESIGN: Prospective observational study.
SETTING: Monocentric, Hopital Nord, Marseille, France.
SUBJECTS: Patients with cardiogenic shock (n = 16), acute heart failure (n = 16), and acute myocardial infarction (n = 16).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Arterial adenosine plasma level and A2A receptor expression on peripheral blood mononuclear cells were evaluated by mass spectrometry and Western blot, respectively, at admission and after 24 hours. Hemodynamic parameters, including systemic vascular resistance, were also assessed. Mean adenosine plasma level at admission was significantly higher in patients with cardiogenic shock (2.74 ± 1.03 µM) versus acute heart failure (1.33 ± 0.27) or acute myocardial infarction (1.19 ± 0.27) (normal range, 0.4-0.8 µM) (p < 0.0001). No significant correlation was found between adenosine plasma level and systemic vascular resistance. Mean adenosine plasma level decreased significantly by 24 hours after admission in patients with cardiogenic shock (2.74 ± 1.03 to 1.53 ± 0.68; p < 0.001). Mean A2A receptor expression was significantly lower in patients with cardiogenic shock (1.18 ± 0.11) versus acute heart failure (1.18 ± 0.11 vs 1.39 ± 0.08) (p = 0.005).
CONCLUSIONS: We observed high adenosine plasma level and low A2A receptor expression at admission in patients with cardiogenic shock versus acute heart failure or acute myocardial infarction. This may contribute to the physiopathology of cardiogenic shock.
参考来源
- Gaubert M, Marlinge M, Kerbaul F, et al. Adenosine Plasma Level and A2A Receptor Expression in Patients With Cardiogenic Shock. Crit Care Med. 2018. PMID: 29923934. doi:10.1097/CCM.0000000000003252
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。